Home › High Blood Pressure › Texas › El Paso
High Blood Pressure clinical trials in El Paso, TX
3 studies for High Blood Pressure are looking for participants at sites in and around El Paso (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Academy Of Diabetes, Thyroid And Endocrine, PA, El Paso
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Headlands Research-El Paso, El Paso
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, El Paso
- Clinical Trial Site, El Paso
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL22 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- Durham, NC10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in El Paso
- Obesity10 studies
- Overweight8 studies
- Heart Failure7 studies
- Non-Small Cell Lung Cancer6 studies
- Breast Cancer6 studies
- COPD5 studies
- Metastatic Cancer5 studies
- Burkitt Lymphoma4 studies
- Lung Cancer4 studies
- Asthma4 studies
- Cancer (all types)4 studies
- Idiopathic Pulmonary Fibrosis4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.